- Home
- BURL vs RPRX Comparison
BURL vs RPRX Comparison
Compare BURL & RPRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BURL
- RPRX
- Stock Information
- Founded
- BURL 1972
- RPRX 1996
- Country
- BURL United States
- RPRX United States
- Employees
- BURL N/A
- RPRX N/A
- Industry
- BURL Department/Specialty Retail Stores
- RPRX Biotechnology: Pharmaceutical Preparations
- Sector
- BURL Consumer Discretionary
- RPRX Health Care
- Exchange
- BURL Nasdaq
- RPRX Nasdaq
- Market Cap
- BURL 14.4B
- RPRX 13.9B
- IPO Year
- BURL 2013
- RPRX 2020
- Fundamental
- Price
- BURL $224.53
- RPRX $34.64
- Analyst Decision
- BURL Strong Buy
- RPRX Strong Buy
- Analyst Count
- BURL 14
- RPRX 3
- Target Price
- BURL $317.43
- RPRX $47.33
- AVG Volume (30 Days)
- BURL 1.3M
- RPRX 4.9M
- Earning Date
- BURL 05-29-2025
- RPRX 08-07-2025
- Dividend Yield
- BURL N/A
- RPRX 2.52%
- EPS Growth
- BURL 37.20
- RPRX 37.60
- EPS
- BURL 8.16
- RPRX 2.45
- Revenue
- BURL $10,768,539,000.00
- RPRX $2,263,845,000.00
- Revenue This Year
- BURL $9.78
- RPRX $29.35
- Revenue Next Year
- BURL $9.78
- RPRX $7.58
- P/E Ratio
- BURL $27.86
- RPRX $14.24
- Revenue Growth
- BURL 8.34
- RPRX 1.13
- 52 Week Low
- BURL $212.92
- RPRX $24.05
- 52 Week High
- BURL $298.89
- RPRX $35.38
- Technical
- Relative Strength Index (RSI)
- BURL 41.31
- RPRX 57.70
- Support Level
- BURL $226.69
- RPRX $34.42
- Resistance Level
- BURL $237.11
- RPRX $35.38
- Average True Range (ATR)
- BURL 6.44
- RPRX 0.60
- MACD
- BURL -1.60
- RPRX 0.09
- Stochastic Oscillator
- BURL 12.51
- RPRX 68.13
About BURL Burlington Stores Inc.
Burlington Stores Inc is off-price retailer offering an extensive selection of in-season, fashion-focused merchandise including: women's ready-to-wear apparel, menswear, youth apparel, baby, beauty, footwear, accessories, home, toys, gifts and coats. Company sell a broad selection of desirable, first-quality, current-brand, labeled merchandise acquired directly from nationally recognized manufacturers and other suppliers. Company sell product in category such as Ladies apparel, Accessories and shoes, Home, Mens apparel, Kids apparel and baby and Outerwear.
About RPRX Royalty Pharma plc
Royalty Pharma PLC is the largest buyer of biopharmaceutical royalties. The firm has a portfolio of royalties that entitles it to payments based on the sales of biopharma products. Royalty Pharma receives royalties on more than 35 commercial products, including AbbVie and Johnson & Johnson's Imbruvica (for chronic lymphocytic leukemia and other blood cancers), Biogen's Tysabri (for relapsing forms of multiple sclerosis), Vertex's cystic fibrosis franchise, and 10 development-stage product candidates.